Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Welcome to a page on SAHLSIS-the Sahlgrenska Study on Ischemic Stroke

What is SAHLSIS?

SAHLSIS is a clinical research project on ischemic stroke (cerebral infarction caused by a clot in one of the blood vessels in the brain) performed at the Sahlgrenska Academy at Gothenburg University, in close collaboration with the Sahlgrenska University Hospital.
SAHLSIS is a clinical study, i.e. our research is based on patients with ischemic stroke and healthy individuals who act as controls. All participants in SAHLSIS are from Västra Götaland.

History of SAHLSIS

SAHLSIS started in August 1998 with the goal of recruiting 600 patients with ischemic stroke and an equal number of healthy controls. This goal was reached in 2004. Since then we have continued to recruit new patients to extend the study, and are delighted that more than 950 patients have been included this far. Recently we have also launched a comprehensive 7-year follow-up of the first participants in the study.

The goals are to better understand what increases the risk of stroke and to provide better treatment

The goal of SAHLSIS is to increase knowledge about stroke risk factors, so that people at high risk of stroke can be helped preventatively. Furthermore, we want to contribute to the development of a better post stroke care and rehabilitation so that all patients can maximize their functional potential after stroke.

SAHLSIS is a large study encompassing several different research areas

The SAHLSIS research team is made up of talented researchers with diverse areas of expertise. This enables us to learn more about ischemic stroke and about the life situation of the patients and their families from very diverse perspectives. Scientists within the project have expertise in areas such as medicine, neurology, cell biology, psychology, cognition, genetics, nursing, health economics and statistics.

Some of the questions we want to answer through our research are:

 

Thank you!

We want to thank all participants in SAHLSIS. Without you this valuable research would not have been possible! We hope you want to continue to be involved in supporting our research!

We would also like to thank:
-Relatives
-Those who contribute financially to our research

Financial support:

  • Vetenskapsrådet
  • Hjärt-Lungfonden
  • STROKE-riksförbundet
  • Hjärnfonden
  • Insamlingsstiftelsen för neurologisk forskning
  • Stiftelsen Emelle fond
  • Tore Nilssons stiftelse för medicinsk forskning
  • Stiftelsen Lars Hiertas minne
  • O.E. och Edla Johanssons vetenskapliga stiftelse
  • John och Brit Wennerströms stiftelse för neurologisk forskning
  • Rune och Ulla Amlövs stiftelse för neurologisk, reumatologisk och audiologisk forskning
  • Edit Jacobsons donationsfond
  • Wilhelm och Martina Lundgrens vetenskaps- och understödsfonder
  • Göteborgs läkarsällskap
  • Svenska läkaresällskapet
  • Per-Olof Alhs stiftelse
  • Magnus Bergvalls stiftelse
  • Yngve Lands stiftelse
  • Märta Lundqvists stiftelse
  • ALF 

 

What is ischemic stroke?

Ischemic stroke is a cerebral infarction caused by a clot in one of the blood vessels supplying blood to the brain. The clot prevents the blood from running, this leads to oxygen depletion and cell death in some parts of the brain.

The chief responsible for SAHLSIS

Christina Jern, Professor
christina.jern@neuro.gu.se

Katarina Jood, MD
katarina.jood@neuro.gu.se

Christian Blomstrand, Professor
christian.blomstrand@neuro.gu.se

Links 

The Swedish Heart-Lung Foundation

Page Manager: Katinka Almrén|Last update: 6/8/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?